Meda Pharmaceuticals

Sky Way House, Parsonage Road, Takeley, Bishop's Stortford, CM22 6PU
Telephone: 0845 460 0000
Fax: 0845 460 0002
Medical Information Direct Line: +44 (0)1748 828 810
Medical Information e-mail: meda@professionalinformation.co.uk
Medical Information Fax: +44 (0)1748 828 801
Out of Hours e-mail: +44 (0)1748 828 810
Summary of Product Characteristics last updated on the eMC: 20/11/2009
SPC Salbulin MDPI Novolizer 100mcg Inhalation Powder

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Nov-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Changes to sections 7., 8., 09., and 10 following change of ownership approval
Updated on 07/05/2008 and displayed until 20/11/2009
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   salbutamol sulphate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk